Biosimilars Comparable to Aflibercept in Macular Disease ...Middle East

Medscape - News
Phase 3 registration trials found the comparability of two biosimilars to reference aflibercept in terms of efficacy, safety, pharmacokinetics, and immunogenicity. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Biosimilars Comparable to Aflibercept in Macular Disease )

Apple Storegoogle play

Also on site :



Latest News